← Leaderboards
Bani Tamraz
University Of California, San Francisco
$335,205
Attributed
$464,360
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $258.3K · FY2024–25$500K$375K$250K$125K$0
'24
'25
Funding mix
By agency
NIH$464,360 · 1
By mechanism
R21$464,360 · 1
Top collaborators
- Pirro G Hysi1 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Diane V Havlir$125,216,731
- Daniel B Vigneron$43,424,992
- William A Weiss$31,543,847
- Jon David Levine$42,152,746
- Monica Gandhi$27,077,063
Others in their field
Other Rising Stars on “Women&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Karen L Florio · University Of Missouri Kansas City$2,288,976
- Abbi Danielle Lane · University Of Michigan At Ann Arbor$2,125,559
- Jeremy Joseph Pruzin · Utah State Higher Education System--University Of Utah$1,929,922
- Sanika Samuel Chirwa · Meharry Medical College$1,756,675
- Tatyana Kushner · Icahn School Of Medicine At Mount Sinai$1,387,120
Research focus
Women&AposAdverse EffectsDoseAnalysis PipelineAnti-Retroviral AgentsAntiretroviral TherapyAspirinBiological MarkersBloodClinically SignificantCohortCohort StudiesData SetDiphosphatesAffectDrug ControlsDrug ExposureDrug KineticsDrug MetabolismEffectivenessEscitalopramEthnic DiversityEthnic OriginAdherence
Grant awards (2)
Quantifying genomic and pharmacometabolomic differences in antiretroviral exposure in MACS/WIHS Combined Cohort Study$206,050
R21 · FY2025 · AI · contact PI
Quantifying genomic and pharmacometabolomic differences in antiretroviral exposure in MACS/WIHS Combined Cohort Study$258,310
R21 · FY2024 · AI · contact PI